HCA Healthcare Inc. (HCA)
NYSE: HCA
· Real-Time Price · USD
395.42
1.77 (0.45%)
At close: Aug 15, 2025, 3:42 PM
HCA Healthcare Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 18.61B | 18.32B | 18.29B | 17.49B | 17.49B | 17.34B | 17.3B | 16.21B | 15.86B | 15.59B | 15.5B | 14.97B | 14.82B | 14.95B | 15.06B | 15.28B | 14.44B | 13.98B |
Cost of Revenue | 15.64B | 15.47B | 15.44B | 15.08B | 14.76B | 14.78B | 14.5B | 14.12B | 13.56B | 13.16B | 13.08B | 12.83B | 12.52B | 12.74B | 12.68B | 12.8B | 11.95B | 11.64B |
Gross Profit | 2.97B | 2.85B | 2.85B | 2.41B | 2.73B | 2.56B | 2.8B | 2.09B | 2.3B | 2.43B | 2.41B | 2.14B | 2.3B | 2.2B | 2.39B | 2.47B | 2.48B | 2.33B |
Operating Income | 2.97B | 2.85B | 2.85B | 2.41B | 2.73B | 2.56B | 2.8B | 2.09B | 2.3B | 2.43B | 2.41B | 2.14B | 2.3B | 2.2B | 2.39B | 2.47B | 2.48B | 2.33B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 2.42B | 2.33B | 2.13B | 1.91B | 2.24B | 2.25B | 2.35B | 1.63B | 1.81B | 1.92B | 3.3B | 1.7B | 1.76B | 1.81B | 2.59B | 3.16B | 2.12B | 1.97B |
Net Income | 1.65B | 1.61B | 1.44B | 1.27B | 1.46B | 1.59B | 1.61B | 1.08B | 1.19B | 1.36B | 2.08B | 1.13B | 1.16B | 1.27B | 1.81B | 2.27B | 1.45B | 1.42B |
Selling & General & Admin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Expense | 568M | 547M | 528M | 515M | 506M | 512M | 491M | 483M | 485M | 479M | 455M | 446M | 432M | 406M | 389M | 388M | 377M | 393M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.64B | 15.47B | 15.44B | 15.08B | 14.76B | 14.78B | 14.5B | 14.12B | 13.56B | 13.16B | 13.08B | 12.83B | 12.52B | 12.74B | 12.68B | 12.8B | 11.95B | 11.64B |
Income Tax Expense | 524M | 502M | 447M | 424M | 550M | 445M | 484M | 355M | 397M | 379M | 656M | 360M | 381M | 349M | 581M | 685M | 453M | 393M |
Shares Outstanding (Basic) | 241.91M | 249.44M | 252.3M | 259.92M | 263.22M | 263.22M | 265.54M | 271.17M | 274.49M | 276.91M | 277.38M | 285.96M | 292.53M | 302.45M | 305.48M | 318.07M | 328.17M | 338.12M |
Shares Outstanding (Diluted) | 241.91M | 249.44M | 255.31M | 259.92M | 264.07M | 268.02M | 271.19M | 275.42M | 278.2M | 280.96M | 285.66M | 289.85M | 296.06M | 307.37M | 315.42M | 324.03M | 332.61M | 343.32M |
EPS (Basic) | 7.00 | 6.52 | 5.70 | 4.94 | 5.60 | 6.04 | 6.05 | 3.98 | 4.35 | 4.92 | 7.50 | 3.97 | 3.95 | 4.21 | 5.94 | 7.13 | 4.42 | 4.21 |
EPS (Diluted) | 6.83 | 6.45 | 5.63 | 4.89 | 5.53 | 5.94 | 5.93 | 3.92 | 4.29 | 4.85 | 7.28 | 3.91 | 3.90 | 4.14 | 5.75 | 7.00 | 4.36 | 4.14 |
EBITDA | 3.85B | 3.73B | 3.52B | 3.26B | 3.56B | 3.55B | 3.63B | 2.88B | 3.06B | 3.16B | 4.51B | 2.9B | 2.93B | 2.95B | 3.7B | 4.26B | 3.21B | 3.06B |
EBIT | 2.98B | 2.87B | 2.66B | 2.42B | 2.74B | 2.76B | 2.84B | 2.11B | 2.29B | 2.4B | 3.76B | 2.15B | 2.19B | 2.22B | 2.98B | 3.54B | 2.49B | 2.37B |
Depreciation & Amortization | 863M | 860M | 856M | 842M | 819M | 795M | 789M | 769M | 763M | 756M | 750M | 749M | 738M | 732M | 728M | 716M | 712M | 697M |